Bora Pharmaceuticals Capabilities Update January 2026: Fill/ Finish

Bora Pharmaceuticals is a full-service global CDMO specializing in the development and manufacturing of complex oral solid, liquid, semi-solid, ophthalmic, biologics, and sterile injectable pharmaceutical products for clinical and commercial supply. Our comprehensive solutions and expansive global network enable our clients to deliver much-needed therapies to patients worldwide.

In this presentation, Tim Lane, Director of Business Development, and Eugene Kim, Director of Supply Chain, will provide an update on Bora’s latest investments and expanded fill/finish capacity for small molecules, biologics and other sterile injectable products.

With extensive experience in tech transfer and scale up to commercialization, Bora is well equipped to support your unique cGMP program needs.